Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial

•Both low and moderate doses of hydroxyurea are efficacious for secondary stroke prevention in low-resource settings.•The median time between the initial stroke and death was less than a year, 0.8 years (interquartile range, 0.2-0.9).